Cargando…
Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties
Major depressive disorder is an extremely debilitating condition affecting millions of people worldwide. Nevertheless, currently available antidepressant medications still have important limitations, such as a low response rate and a time lag for treatment response that represent a significant probl...
Autores principales: | Zunszain, P A, Horowitz, M A, Cattaneo, A, Lupi, M M, Pariante, C M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835937/ https://www.ncbi.nlm.nih.gov/pubmed/23877835 http://dx.doi.org/10.1038/mp.2013.87 |
Ejemplares similares
-
Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice
por: Ma, Xian-Cang, et al.
Publicado: (2013) -
Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor
por: Anacker, C, et al.
Publicado: (2011) -
Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells
por: Horowitz, Mark Abie, et al.
Publicado: (2015) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Evaluation of Glycogen Synthase Kinase Pathway for Assessing the Antidepressant-like Effect of Glucosamine as a Radioprotector in Rats: Behavioral and Biochemical Studies
por: Mekkawy, Mai H., et al.
Publicado: (2023)